ASPH
Basic information
Region (hg38): 8:61500556-61714640
Links
Phenotypes
GenCC
Source:
- facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome (Strong), mode of inheritance: AR
- facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome (Supportive), mode of inheritance: AR
- facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Traboulsi syndrome | AR | Ophthalmologic | Early surgical removal of the lens has been reported as necessary in order to preserve visual function by preventing irreversible corneal and trabecular meshwork damage | Craniofacial; Ophthalmologic | 11241487; 23687502; 24768550 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (4 variants)
- Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASPH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 19 | 24 | ||||
missense | 43 | 54 | ||||
nonsense | 7 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 2 | 3 | 5 | 11 | |
non coding | 48 | 57 | ||||
Total | 6 | 4 | 45 | 38 | 56 |
Variants in ASPH
This is a list of pathogenic ClinVar variants found in the ASPH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-61503378-C-A | Inborn genetic diseases | Uncertain significance (May 30, 2023) | ||
8-61503378-C-T | Inborn genetic diseases | Uncertain significance (Jan 28, 2023) | ||
8-61503410-C-T | Likely benign (Jul 12, 2023) | |||
8-61503433-G-A | Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome | Pathogenic (May 01, 2014) | ||
8-61503452-C-CCAT | Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome | Pathogenic (Jun 17, 2021) | ||
8-61503457-C-T | Uncertain significance (Aug 15, 2022) | |||
8-61503461-G-A | Likely benign (Sep 20, 2023) | |||
8-61503490-C-T | Inborn genetic diseases | Uncertain significance (Jan 19, 2024) | ||
8-61503506-G-C | Likely benign (Apr 15, 2023) | |||
8-61503509-C-A | Uncertain significance (Jul 03, 2022) | |||
8-61503510-CT-C | Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome | Pathogenic/Likely pathogenic (Jan 26, 2024) | ||
8-61503515-G-A | Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome | Benign (Jan 31, 2024) | ||
8-61503516-C-CAGAA | Likely benign (Aug 17, 2023) | |||
8-61503614-G-A | Benign (Sep 04, 2018) | |||
8-61517549-A-G | Inborn genetic diseases | Uncertain significance (Jun 29, 2022) | ||
8-61517570-A-T | Inborn genetic diseases | Uncertain significance (Aug 22, 2023) | ||
8-61517583-G-T | Inborn genetic diseases | Uncertain significance (Mar 08, 2024) | ||
8-61517629-G-A | Benign (Mar 20, 2022) | |||
8-61517649-T-C | Inborn genetic diseases | Likely benign (Jan 07, 2022) | ||
8-61518052-T-C | Likely benign (Jul 17, 2023) | |||
8-61518107-A-AT | Pathogenic (Jun 13, 2021) | |||
8-61525971-A-G | Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome | Benign (Jan 31, 2024) | ||
8-61525985-C-T | Pathogenic (Sep 21, 2022) | |||
8-61525990-C-A | Likely benign (May 15, 2022) | |||
8-61526021-AGGTT-CCC | Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome | Pathogenic (May 01, 2014) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASPH | protein_coding | protein_coding | ENST00000379454 | 25 | 214040 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.63e-15 | 0.987 | 125667 | 0 | 81 | 125748 | 0.000322 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.207 | 388 | 400 | 0.971 | 0.0000209 | 4988 |
Missense in Polyphen | 114 | 144.19 | 0.79064 | 1694 | ||
Synonymous | -0.595 | 156 | 147 | 1.06 | 0.00000825 | 1338 |
Loss of Function | 2.59 | 31 | 51.0 | 0.608 | 0.00000251 | 614 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000903 | 0.000895 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000587 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000365 | 0.000360 |
Middle Eastern | 0.0000587 | 0.0000544 |
South Asian | 0.000394 | 0.000359 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform 1: specifically hydroxylates an Asp or Asn residue in certain epidermal growth factor-like (EGF) domains of a number of proteins. {ECO:0000269|PubMed:11773073}.;
- Pathway
- hypoxia-inducible factor in the cardivascular system;Stimuli-sensing channels;Ion channel transport;Ion homeostasis;Transport of small molecules;Cardiac conduction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.181
Intolerance Scores
- loftool
- 0.988
- rvis_EVS
- -1.24
- rvis_percentile_EVS
- 5.52
Haploinsufficiency Scores
- pHI
- 0.0978
- hipred
- Y
- hipred_score
- 0.544
- ghis
- 0.552
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.658
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asph
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- muscle contraction;pattern specification process;negative regulation of cell population proliferation;electron transport chain;regulation of protein stability;ion transmembrane transport;limb morphogenesis;peptidyl-aspartic acid hydroxylation;positive regulation of proteolysis;roof of mouth development;face morphogenesis;activation of cysteine-type endopeptidase activity;regulation of protein depolymerization;regulation of cardiac conduction
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;integral component of membrane;cortical endoplasmic reticulum;sarcoplasmic reticulum membrane
- Molecular function
- peptide-aspartate beta-dioxygenase activity;structural molecule activity;calcium ion binding;protein binding;structural constituent of muscle;electron transfer activity